The Antibody Society is an international non-profit comprising individuals and organizations involved in antibody-related research and development and related fields. The Society has a variety of initiatives and working groups focused on advancing the antibody field. In particular, we:
Create opportunities for education and networking
Establish standards for next-generation sequencing
Monitor and report on advances in the commercial pipeline of antibody-based therapeutics
Engage government and international agencies on matters concerning the antibody community
Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field.
Our widespread and market specific content write-ups cater to Industry professionals intending to keep pace with this dynamic and revolutionary industry. Articles like the latest news, trends, analysis, market reports, press releases, whitepapers, case studies, etc. enable further insight as well as an in-depth interpretation of industry trends.
Our editorial staff is committed to disseminating concise facts and information to its readers and subscribers by collating credible information from known sources and decoding them in the form of innumerable content pieces. Ranging from objective facts to subjective, analytical studies enables a holistic view of the topics scouted for.
It is noteworthy that Pharma Journalist which is a product of Kellen Media also offers a plethora of online marketing services aiding companies and organizations to reach out to targeted audience based on the geographical and demographic profiles ensuring enhanced reach and visibility garnered for their products or events paving way for accentuated brand awareness.
The Chinese Antibody Society is a nonprofit professional organization focusing on therapeutic antibodies and relevant therapeutic modalities. Our mission is to build a platform that facilitates the communication and collaboration of the global community in the discovery, development, manufacturing, and commercialization of antibody-based products.